Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lisuride (Dopergin) (2 trials)
ropinirole (Requip) (1 trial)
Parkinson Disease (Phase 3)
Psychomotor Agitation (Phase 3)
Restless Legs Syndrome (Phase 3)
Syndrome (Phase 3)
Trials (2 total)
Trial APIs (2 total)